Sarada Medical Diagonistic Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.30 M
as on 19-12-2024
- Revenue %
(FY 2021)
- Profit 48.08%
(FY 2021)
- Ebitda 48.08%
(FY 2021)
- Net Worth -10.04%
(FY 2021)
- Total Assets -0.11%
(FY 2021)
About Sarada Medical Diagonistic Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.30 M.
Sumita Podder, Gopal Podder, and Sagar Podder serve as directors at the Company.
- CIN/LLPIN
U85110WB2010PTC155460
- Company No.
155460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarada Medical Diagonistic Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumita Podder  | Director | 07-Dec-2010 | Current |
| Gopal Podder | Director | 07-Dec-2010 | Current |
| Sagar Podder | Director | 30-Dec-2021 | Current |
Financial Performance of Sarada Medical Diagonistic Centre.
Sarada Medical Diagonistic Centre Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 48.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarada Medical Diagonistic Centre?
In 2020, Sarada Medical Diagonistic Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- S.B.Infratech Engineering Co Private LimitedActive 13 years 11 months
Sumita Podder and Gopal Podder are mutual person
- Luv Kush Vanijya Private LimitedActive 17 years 2 months
Sumita Podder and Gopal Podder are mutual person
- Sarada Holiday Home & Resorts Private LimitedActive 14 years 1 month
Sumita Podder, Gopal Podder and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jan 2022 | ₹9.30 M | Open |
How Many Employees Work at Sarada Medical Diagonistic Centre?
Unlock and access historical data on people associated with Sarada Medical Diagonistic Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarada Medical Diagonistic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarada Medical Diagonistic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
